Vanguard Capital Management
CALC icon

Vanguard Capital Management’s CalciMedica CALC Stock Holding History

Vanguard Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.6K Sell
88,956
-80,154
-47% -$56.8K ﹤0.01% 3883
2026
Q1 		$91.3K Buy
+169,110
New +$343K ﹤0.01% 3871

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Vanguard Capital Management's CALC Position: Q2 2026 in Review

Vanguard Capital Management reduced its CalciMedica (CALC) stake by 47% in Q2 2026, selling an estimated $56.8K and leaving 88,956 shares worth $91.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

Vanguard Capital Management first reported a position in CALC in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Vanguard Capital Management held 88,956 shares of CalciMedica worth $91.6K as of Q2 2026.
  • Vanguard Capital Management sold 80,154 CalciMedica shares in Q2 2026, an estimated $56.8K.
  • CalciMedica made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3883 holding.
  • Vanguard Capital Management first reported a position in CalciMedica in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.